(a) represents 18F-FDG-PET/CT imaging showing multifocal hypermetabolic lesions of the sacroiliac joints, lungs and axillary, cervical, supraclavicular lymphadenopathy suggestive of systemic disease. (b) represents 18F-FDG-PET/CT imaging one year after antituberculosis treatment. All hypermetabolic lesions have been cleared, confirming efficient therapy of tuberculosis.
